FR2673104A1 - Compositions pharmaceutiques de sterouide anti-inflammatoire en suspension aqueuse, pour administration nasale. - Google Patents

Compositions pharmaceutiques de sterouide anti-inflammatoire en suspension aqueuse, pour administration nasale. Download PDF

Info

Publication number
FR2673104A1
FR2673104A1 FR9202105A FR9202105A FR2673104A1 FR 2673104 A1 FR2673104 A1 FR 2673104A1 FR 9202105 A FR9202105 A FR 9202105A FR 9202105 A FR9202105 A FR 9202105A FR 2673104 A1 FR2673104 A1 FR 2673104A1
Authority
FR
France
Prior art keywords
composition
composition according
tipredane
surfactant
nose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR9202105A
Other languages
English (en)
French (fr)
Inventor
Saunders Joy Elaine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FISONS AG
Original Assignee
FISONS AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FISONS AG filed Critical FISONS AG
Publication of FR2673104A1 publication Critical patent/FR2673104A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
FR9202105A 1991-02-23 1992-02-24 Compositions pharmaceutiques de sterouide anti-inflammatoire en suspension aqueuse, pour administration nasale. Withdrawn FR2673104A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation

Publications (1)

Publication Number Publication Date
FR2673104A1 true FR2673104A1 (fr) 1992-08-28

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9202105A Withdrawn FR2673104A1 (fr) 1991-02-23 1992-02-24 Compositions pharmaceutiques de sterouide anti-inflammatoire en suspension aqueuse, pour administration nasale.

Country Status (13)

Country Link
CN (1) CN1065010A (el)
AU (1) AU1247192A (el)
BE (1) BE1004177A4 (el)
FR (1) FR2673104A1 (el)
GB (1) GB9103824D0 (el)
GR (1) GR1001511B (el)
IE (1) IE920516A1 (el)
IL (1) IL101010A0 (el)
IT (1) IT1254627B (el)
MX (1) MX9200748A (el)
PT (1) PT100150A (el)
WO (1) WO1992014473A1 (el)
ZA (1) ZA921247B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2057982A1 (en) * 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
EP3694524A1 (en) * 2017-10-11 2020-08-19 Lifescience AS N-acetylneuraminic acid compositions and methods of use
MX2021009595A (es) * 2019-02-11 2021-09-08 Reckitt Benckiser Health Ltd Composicion novedosa.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073026A1 (en) * 1981-08-20 1983-03-02 E.R. Squibb & Sons, Inc. 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions
EP0246652A2 (en) * 1986-05-22 1987-11-25 Syntex Pharmaceuticals International Limited Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
WO1991011173A1 (en) * 1990-02-02 1991-08-08 Fisons Plc Propellant compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0073026A1 (en) * 1981-08-20 1983-03-02 E.R. Squibb & Sons, Inc. 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions
EP0246652A2 (en) * 1986-05-22 1987-11-25 Syntex Pharmaceuticals International Limited Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
WO1991011173A1 (en) * 1990-02-02 1991-08-08 Fisons Plc Propellant compositions

Also Published As

Publication number Publication date
PT100150A (pt) 1993-05-31
IE920516A1 (en) 1992-08-26
AU1247192A (en) 1992-09-15
GB9103824D0 (en) 1991-04-10
IT1254627B (it) 1995-09-28
WO1992014473A1 (en) 1992-09-03
IL101010A0 (en) 1992-11-15
GR1001511B (el) 1994-02-28
ITMI920393A1 (it) 1993-08-21
CN1065010A (zh) 1992-10-07
MX9200748A (es) 1992-10-01
BE1004177A4 (fr) 1992-10-06
ITMI920393A0 (it) 1992-02-21
ZA921247B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
BE1004177A4 (fr) Compositions de steroide.
TWI287992B (en) Compositions containing therapeutically active components having enhanced solubility
JP3903061B2 (ja) 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤
EP1513493B1 (en) Analgesics
JP5044404B2 (ja) ロフルミラストを含有する水性医薬調剤
FR2737121A1 (fr) Nouvelles formulations galeniques du fenofibrate et leurs applications
JPH06263630A (ja) ビタミンａ類可溶化点眼剤
WO2006031848A2 (en) Corticosteroid topical dispersion with low content of surfactant
JP2011503105A (ja) バルサルタン含有液体組成物
JP2011513304A (ja) 酒さを処置するためのダプソン
LU82360A1 (fr) Compositions injectables a base d'oxytetracycline
KR20040063943A (ko) 안과 질환 및 질병의 치료를 위한 과산화물 디스뮤타제모방체
JP2003512330A (ja) シクレソニド含有水性医薬組成物
NZ542218A (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetic acid
FR2788436A1 (fr) Composition d'un derive de phenothiazine
EP0599943A1 (en) Leukotriene receptor antagonist-antihistamine complex
FR2680106A1 (fr) Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
EP1835906A1 (fr) Formulations injectables ou administrables par voie orale de derives d'azetidine
FR2755857A1 (fr) Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
JP4524559B2 (ja) 眼科用組成物及びビタミンａ類の安定化方法
JP2003055201A (ja) ビタミンａ類含有可溶化組成物及びビタミンａ類の安定化方法
WO2001087303A1 (fr) Preparation liquide aqueuse
EP1653963B1 (fr) Composition pharmaceutique nasale de piribedil
JP2007016024A (ja) ロフルミラスト点眼液
JP2019524879A (ja) リソソーム蓄積症およびその他の単一遺伝子代謝疾患を処置および／または予防するための組成物および方法

Legal Events

Date Code Title Description
ST Notification of lapse